Microfluidic technology for sustained release formulation of proteins or pharmaceuticals

Sustained release formulation by means of microfluidic technology (adopted by Profarma for proteins), allows for controlled release of proteins, peptides or small molecules  for longer periods. Several systems for microdroplets formation are developed, using biodegradable systems  with no chemical cross-linking

Microfluidic technology allows insertion of protein into the droplets with an extremely narrow size variation

Microfluidic processes provide unique control over the droplet formation and thus final particle characteristics

Each droplet is individually formed in separate channels resulting highly uniform distribution of the particle size






V.A. Graiciuno 6, LT-02241,
Vilnius, Lithuania

Tel. +370 5 2629761,
E-mail: info@profarma.lt